EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Asthma Biologics

Justin D Salciccioli, Elliot Israel

Immunology and Allergy Clinics of North America · 2024

DOI: 10.1016/j.iac.2024.08.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology and Allergy Clinics of North America, 2024. Verfasst von Justin D Salciccioli und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Ele…. Hauptthemen laut MEDLINE: Asthma, Biological Products, Anti-Asthmatic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of multiple targeted biologic therapies over the past two decades has revolutionized the management of asthma. Currently, there are 6 monoclonal antibodies that target specific inflammatory mediators involved in the pathophysiology of asthma, and together, they provide the opportunity for personalized treatment options beyond bronchodilators and inhaled or systemic glucocorticoids in severe and difficult-to-control cases of asthma. These agents are the anti-IgE antibody omalizumab, the anti-IL-5 antibodies mepolizumab and reslizumab, the IL-5 receptor alpha antagonist benralizumab, the IL-4 receptor alpha antagonist dupilumab, and the anti-thymic stromal lymphopoietin antibody tezepelumab.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaBiological ProductsAnti-Asthmatic AgentsHumansAntibodies, MonoclonalDisease ProgressionRespiratory Function TestsLungInterleukin-5Steroids

Stichwörter der Autor:innen

AsthmaBronchodilatorsExacerbationGlucocorticoids

Substanzen

Biological ProductsAnti-Asthmatic AgentsAntibodies, MonoclonalInterleukin-5Steroids

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address: jsalciccioli@bwh.harvard.edu.
  • Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA; Division of Allergy and Immunology, Brigham and Women's Hospital, Harvard…

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Salciccioli, J. D., & Israel, E. (2024). Asthma Biologics. Immunology and Allergy Clinics of North America. https://doi.org/10.1016/j.iac.2024.08.002

Vancouver

Salciccioli JD, Israel E. Asthma Biologics. Immunology and Allergy Clinics of North America. 2024. doi:10.1016/j.iac.2024.08.002

BibTeX
@article{Salciccioli2024,
  author = {Salciccioli, Justin D and Israel, Elliot},
  title = {Asthma Biologics},
  journal = {Immunology and Allergy Clinics of North America},
  year = {2024},
  doi = {10.1016/j.iac.2024.08.002}
}
Kostenlos starten →